: Suppliers use Healthcare Common Procedure Coding System (HCPCS) code Q2052 for home administration services. Market and Cost Overview (Assumed 2024–2026)
: The U.S. IVIG market was valued at approximately $5.74 billion in 2022 and is projected to grow through 2030 due to increased demand for replacement therapies.
: Medicare payment amounts for administration services (Q2052) have seen annual increases, with the 2025 allowable amount reported at $431.83.
: As of January 1, 2024, Medicare Part B provides a permanent benefit for the supplies and services needed to receive IVIG at home for patients with PI.
: Most acquisitions involve prior authorization. Private insurers and Medicare have specific criteria for coverage, often requiring proof of a confirmed diagnosis like Primary Immunodeficiency (PI). Medicare and Home Access